患者由来の異種移植片/ PDXモデルの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Patient Derived Xenograft/PDX Models Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8104978)・商品コード:GIR8104978
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月11日(※2024年版があります。お問い合わせください)
・ページ数:131
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、患者由来の異種移植片/ PDXモデルの世界市場について調べ、まとめました。種類別セグメントは、マウスモデル、ラットモデル等、用途別セグメントは、前臨床医薬品開発と基礎がん研究、バイオマーカー分析等に区分しました。患者由来の異種移植片/ PDXモデルの世界市場概観、メーカー動向、メーカー別患者由来の異種移植片/ PDXモデルシェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・患者由来の異種移植片/ PDXモデルの市場概観
・患者由来の異種移植片/ PDXモデルのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・患者由来の異種移植片/ PDXモデルのメーカー別販売動向、市場シェア、市場集中度、競争動向
・患者由来の異種移植片/ PDXモデルの世界市場規模
・患者由来の異種移植片/ PDXモデルの北米市場分析(アメリカ、カナダ、メキシコ等)
・患者由来の異種移植片/ PDXモデルのアメリカ市場規模推移
・患者由来の異種移植片/ PDXモデルのカナダ市場規模推移
・患者由来の異種移植片/ PDXモデルのメキシコ市場規模推移
・患者由来の異種移植片/ PDXモデルのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・患者由来の異種移植片/ PDXモデルのドイツ市場規模推移
・患者由来の異種移植片/ PDXモデルのイギリス市場規模推移
・患者由来の異種移植片/ PDXモデルのロシア市場規模推移
・患者由来の異種移植片/ PDXモデルのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・患者由来の異種移植片/ PDXモデルの日本市場規模推移
・患者由来の異種移植片/ PDXモデルの中国市場規模推移
・患者由来の異種移植片/ PDXモデルの韓国市場規模推移
・患者由来の異種移植片/ PDXモデルのインド市場規模推移
・患者由来の異種移植片/ PDXモデルの東南アジア市場規模推移
・患者由来の異種移植片/ PDXモデルの南米市場分析(ブラジル、アルゼンチン等)
・患者由来の異種移植片/ PDXモデルの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・患者由来の異種移植片/ PDXモデルの種類別分析/市場規模推移(マウスモデル、ラットモデル)
・患者由来の異種移植片/ PDXモデルの用途別分析/市場規模推移(前臨床医薬品開発と基礎がん研究、バイオマーカー分析)
・患者由来の異種移植片/ PDXモデルの市場予測(地域別予測、種類別予測、用途別予測)
・患者由来の異種移植片/ PDXモデルの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient’s tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.

Scope of the Report:

This report studies the Patient Derived Xenograft/PDX Models market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Patient Derived Xenograft/PDX Models market by product type and applications/end industries.

Several types of immunodeficient mice can be used to establish PDX models: athymic nude mice, severely compromised immune deficient (SCID) mice, NOD-SCID mice, and recombination-activating gene 2 (Rag2)-knockout mice. The mice used must be immunocompromised to prevent transplant rejection. The NOD-SCID mouse is considered more immunodeficient than the nude mouse, and therefore is more commonly used for PDX models because the NOD-SCID mouse does not produce natural killer cells.

The global Patient Derived Xenograft/PDX Models market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Patient Derived Xenograft/PDX Models.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Crown Bioscience

The Jackson Laboratory

Champions Oncology

Charles River Laboratories

WuXi Apptec

Oncodesign

Horizon Discovery

Pharmatest Services

Hera Biolabs

EPO Berlin-Buch

Xentech

Urolead

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Mice Models

Rat Models

Market Segment by Applications, can be divided into

Pre-clinical Drug Development and Basic Cancer Research

Biomarker Analysis

【レポートの目次】

Table of Contents

1 Patient Derived Xenograft/PDX Models Market Overview

1.1 Product Overview and Scope of Patient Derived Xenograft/PDX Models

1.2 Classification of Patient Derived Xenograft/PDX Models by Types

1.2.1 Global Patient Derived Xenograft/PDX Models Revenue Comparison by Types (2017-2023)

1.2.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Types in 2017

1.2.3 Mice Models

1.2.4 Rat Models

1.3 Global Patient Derived Xenograft/PDX Models Market by Application

1.3.1 Global Patient Derived Xenograft/PDX Models Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Pre-clinical Drug Development and Basic Cancer Research

1.3.3 Biomarker Analysis

1.4 Global Patient Derived Xenograft/PDX Models Market by Regions

1.4.1 Global Patient Derived Xenograft/PDX Models Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Patient Derived Xenograft/PDX Models Status and Prospect (2013-2023)

1.5 Global Market Size of Patient Derived Xenograft/PDX Models (2013-2023)

2 Manufacturers Profiles

2.1 Crown Bioscience

2.1.1 Business Overview

2.1.2 Patient Derived Xenograft/PDX Models Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Crown Bioscience Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.2 The Jackson Laboratory

2.2.1 Business Overview

2.2.2 Patient Derived Xenograft/PDX Models Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 The Jackson Laboratory Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.3 Champions Oncology

2.3.1 Business Overview

2.3.2 Patient Derived Xenograft/PDX Models Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Champions Oncology Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.4 Charles River Laboratories

2.4.1 Business Overview

2.4.2 Patient Derived Xenograft/PDX Models Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Charles River Laboratories Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.5 WuXi Apptec

2.5.1 Business Overview

2.5.2 Patient Derived Xenograft/PDX Models Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.6 Oncodesign

2.6.1 Business Overview

2.6.2 Patient Derived Xenograft/PDX Models Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Oncodesign Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.7 Horizon Discovery

2.7.1 Business Overview

2.7.2 Patient Derived Xenograft/PDX Models Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Horizon Discovery Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.8 Pharmatest Services

2.8.1 Business Overview

2.8.2 Patient Derived Xenograft/PDX Models Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Pharmatest Services Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.9 Hera Biolabs

2.9.1 Business Overview

2.9.2 Patient Derived Xenograft/PDX Models Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.10 EPO Berlin-Buch

2.10.1 Business Overview

2.10.2 Patient Derived Xenograft/PDX Models Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.11 Xentech

2.11.1 Business Overview

2.11.2 Patient Derived Xenograft/PDX Models Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Xentech Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

2.12 Urolead

2.12.1 Business Overview

2.12.2 Patient Derived Xenograft/PDX Models Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Urolead Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

3 Global Patient Derived Xenograft/PDX Models Market Competition, by Players

3.1 Global Patient Derived Xenograft/PDX Models Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Patient Derived Xenograft/PDX Models Players Market Share

3.2.2 Top 10 Patient Derived Xenograft/PDX Models Players Market Share

3.3 Market Competition Trend

4 Global Patient Derived Xenograft/PDX Models Market Size by Regions

4.1 Global Patient Derived Xenograft/PDX Models Revenue and Market Share by Regions

4.2 North America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

4.3 Europe Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

4.5 South America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

5 North America Patient Derived Xenograft/PDX Models Revenue by Countries

5.1 North America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)

5.2 USA Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

5.3 Canada Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

5.4 Mexico Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

6 Europe Patient Derived Xenograft/PDX Models Revenue by Countries

6.1 Europe Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)

6.2 Germany Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

6.3 UK Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

6.4 France Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

6.5 Russia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

6.6 Italy Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue by Countries

7.1 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)

7.2 China Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

7.3 Japan Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

7.4 Korea Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

7.5 India Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

8 South America Patient Derived Xenograft/PDX Models Revenue by Countries

8.1 South America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)

8.2 Brazil Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

8.3 Argentina Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

8.4 Colombia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Patient Derived Xenograft/PDX Models by Countries

9.1 Middle East and Africa Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)

9.2 Saudi Arabia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

9.3 UAE Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

9.4 Egypt Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

9.5 Nigeria Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

9.6 South Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

10 Global Patient Derived Xenograft/PDX Models Market Segment by Type

10.1 Global Patient Derived Xenograft/PDX Models Revenue and Market Share by Type (2013-2018)

10.2 Global Patient Derived Xenograft/PDX Models Market Forecast by Type (2018-2023)

10.3 Mice Models Revenue Growth Rate (2013-2023)

10.4 Rat Models Revenue Growth Rate (2013-2023)

11 Global Patient Derived Xenograft/PDX Models Market Segment by Application

11.1 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2013-2018)

11.2 Patient Derived Xenograft/PDX Models Market Forecast by Application (2018-2023)

11.3 Pre-clinical Drug Development and Basic Cancer Research Revenue Growth (2013-2018)

11.4 Biomarker Analysis Revenue Growth (2013-2018)

12 Global Patient Derived Xenograft/PDX Models Market Size Forecast (2018-2023)

12.1 Global Patient Derived Xenograft/PDX Models Market Size Forecast (2018-2023)

12.2 Global Patient Derived Xenograft/PDX Models Market Forecast by Regions (2018-2023)

12.3 North America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

12.4 Europe Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

12.6 South America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Patient Derived Xenograft/PDX Models Picture

Table Product Specifications of Patient Derived Xenograft/PDX Models

Table Global Patient Derived Xenograft/PDX Models and Revenue (Million USD) Market Split by Product Type

Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Types in 2017

Figure Mice Models Picture

Figure Rat Models Picture

Table Global Patient Derived Xenograft/PDX Models Revenue (Million USD) by Application (2013-2023)

Figure Patient Derived Xenograft/PDX Models Revenue Market Share by Applications in 2017

Figure Pre-clinical Drug Development and Basic Cancer Research Picture

Figure Biomarker Analysis Picture

Table Global Market Patient Derived Xenograft/PDX Models Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (2013-2023)

Table Crown Bioscience Basic Information, Manufacturing Base and Competitors

Table Crown Bioscience Patient Derived Xenograft/PDX Models Type and Applications

Table Crown Bioscience Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table The Jackson Laboratory Basic Information, Manufacturing Base and Competitors

Table The Jackson Laboratory Patient Derived Xenograft/PDX Models Type and Applications

Table The Jackson Laboratory Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Champions Oncology Basic Information, Manufacturing Base and Competitors

Table Champions Oncology Patient Derived Xenograft/PDX Models Type and Applications

Table Champions Oncology Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Charles River Laboratories Basic Information, Manufacturing Base and Competitors

Table Charles River Laboratories Patient Derived Xenograft/PDX Models Type and Applications

Table Charles River Laboratories Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table WuXi Apptec Basic Information, Manufacturing Base and Competitors

Table WuXi Apptec Patient Derived Xenograft/PDX Models Type and Applications

Table WuXi Apptec Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Oncodesign Basic Information, Manufacturing Base and Competitors

Table Oncodesign Patient Derived Xenograft/PDX Models Type and Applications

Table Oncodesign Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Horizon Discovery Basic Information, Manufacturing Base and Competitors

Table Horizon Discovery Patient Derived Xenograft/PDX Models Type and Applications

Table Horizon Discovery Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Pharmatest Services Basic Information, Manufacturing Base and Competitors

Table Pharmatest Services Patient Derived Xenograft/PDX Models Type and Applications

Table Pharmatest Services Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Hera Biolabs Basic Information, Manufacturing Base and Competitors

Table Hera Biolabs Patient Derived Xenograft/PDX Models Type and Applications

Table Hera Biolabs Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table EPO Berlin-Buch Basic Information, Manufacturing Base and Competitors

Table EPO Berlin-Buch Patient Derived Xenograft/PDX Models Type and Applications

Table EPO Berlin-Buch Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Xentech Basic Information, Manufacturing Base and Competitors

Table Xentech Patient Derived Xenograft/PDX Models Type and Applications

Table Xentech Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Urolead Basic Information, Manufacturing Base and Competitors

Table Urolead Patient Derived Xenograft/PDX Models Type and Applications

Table Urolead Patient Derived Xenograft/PDX Models Revenue, Gross Margin and Market Share (2016-2017)

Table Global Patient Derived Xenograft/PDX Models Revenue (Million USD) by Players (2013-2018)

Table Global Patient Derived Xenograft/PDX Models Revenue Share by Players (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Players in 2016

Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Players in 2017

Figure Global Top 5 Players Patient Derived Xenograft/PDX Models Revenue Market Share in 2017

Figure Global Top 10 Players Patient Derived Xenograft/PDX Models Revenue Market Share in 2017

Figure Global Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Patient Derived Xenograft/PDX Models Revenue (Million USD) by Regions (2013-2018)

Table Global Patient Derived Xenograft/PDX Models Revenue Market Share by Regions (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Regions (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Regions in 2017

Figure North America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Europe Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure South America Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Table North America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)

Table North America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure North America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure North America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017

Figure USA Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Canada Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Mexico Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Table Europe Patient Derived Xenograft/PDX Models Revenue (Million USD) by Countries (2013-2018)

Figure Europe Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure Europe Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017

Figure Germany Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure UK Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure France Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Russia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Italy Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Patient Derived Xenograft/PDX Models Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017

Figure China Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Japan Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Korea Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure India Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Table South America Patient Derived Xenograft/PDX Models Revenue by Countries (2013-2018)

Table South America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure South America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure South America Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017

Figure Brazil Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Argentina Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Colombia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Patient Derived Xenograft/PDX Models Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Share by Countries in 2017

Figure Saudi Arabia Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure UAE Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Egypt Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure Nigeria Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Figure South Africa Patient Derived Xenograft/PDX Models Revenue and Growth Rate (2013-2018)

Table Global Patient Derived Xenograft/PDX Models Revenue (Million USD) by Type (2013-2018)

Table Global Patient Derived Xenograft/PDX Models Revenue Share by Type (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Type (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Type in 2017

Table Global Patient Derived Xenograft/PDX Models Revenue Forecast by Type (2018-2023)

Figure Global Patient Derived Xenograft/PDX Models Market Share Forecast by Type (2018-2023)

Figure Global Mice Models Revenue Growth Rate (2013-2018)

Figure Global Rat Models Revenue Growth Rate (2013-2018)

Table Global Patient Derived Xenograft/PDX Models Revenue by Application (2013-2018)

Table Global Patient Derived Xenograft/PDX Models Revenue Share by Application (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Application (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue Share by Application in 2017

Table Global Patient Derived Xenograft/PDX Models Revenue Forecast by Application (2018-2023)

Figure Global Patient Derived Xenograft/PDX Models Market Share Forecast by Application (2018-2023)

Figure Global Pre-clinical Drug Development and Basic Cancer Research Revenue Growth Rate (2013-2018)

Figure Global Biomarker Analysis Revenue Growth Rate (2013-2018)

Figure Global Patient Derived Xenograft/PDX Models Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Patient Derived Xenograft/PDX Models Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

Figure Europe Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

Figure South America Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Patient Derived Xenograft/PDX Models Revenue Market Forecast (2018-2023)



【レポートのキーワード】

患者由来の異種移植片/ PDXモデル、マウスモデル、ラットモデル、前臨床医薬品開発と基礎がん研究、バイオマーカー分析

★調査レポート[患者由来の異種移植片/ PDXモデルの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8104978)販売に関する免責事項を必ずご確認ください。
★調査レポート[患者由来の異種移植片/ PDXモデルの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆